Bioreactors and Fermenters market Research Report by 2022, Forecast till 2035

The COVID-19 pandemic highlighted the imperative need for advanced bioreactor and fermenter systems for the production of novel biopharmaceuticals at various scales of operation.

In response to the increased demand for flexible solutions, stakeholders have been actively engaged in developing biomanufacturing equipment with advanced features, including built-in sensors, controllers, and automated systems.

The financial opportunity within the global bioreactors and fermenters market has been analyzed across the following segments:
 Type of Product
 Bioreactors
 Fermenters

 Fabrication Material
 Glass
 Stainless Steel
 Single-use

 Type of Bioprocess
 Batch and Fed-batch
 Continuous

 Type of Biologic
 Antibodies
 Vaccines
 Cell Therapies
 Other Biologics

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Rest of the World

The Global Bioreactors and Fermenters Market, 2023-2035 report also includes profiles of key players (listed below) engaged in manufacturing bioreactors and fermenters; each profile includes a brief overview of the company, along with information on its financial information (if available), product portfolio, recent developments and an informed future outlook.
 Applikon Biotechnology
 Bionet
 Cytiva
 Eppendorf
 Merck
 Ollital Technology
 Parr Instrument Company
 Sartorius
 Shanghai Bailun Biological Technology
 Solaris Biotech
 Solida Biotech
 Zhengzhou Laboao Instrument Equipment (LABAO)


Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Bioreactor and Fermenter Manufacturers: Market Landscape

5. Company Competitiveness Analysis

6. Company Profiles

7. Capacity Analysis

8. Case Study: Bioprocess Controllers and Automation Systems

9. Market Sizing and Opportunity Analysis

10. Concluding Remarks

11. Executive Insights

12. Appendix 1: Tabulated Data

13. Appendix 2: List of Companies and Organizations


To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/bioreactors-

You may also be interested in the following titles:
Global Antibiotics Market

Pharmaceutical Polymers / Medical Polymers Market
women's digital health market

global digital therapeutics market



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#bioreactorsandfermenters #bioreactorsandfermentersmarket #fermentation #fermentationbioreactors #bioreactorsandfermentersmarketsize

Monkeypox Treatment market Trends, Analysis by 2035

The “Monkeypox Treatment Market, 2023-2035” report features an extensive study of the current market landscape and future opportunity for the players focused on the development of monkeypox therapeutics, vaccines and diagnostic kits.

Key Inclusions
 A general introduction to monkeypox virus, along with information on signs and symptoms of the disease, history of monkeypox outbreaks and details on transmission of disease from animals to humans and humans to humans. It also features an overview of the monkeypox disease diagnosis and current therapeutics / vaccines used for the treatment / prevention of the infection and a discussion on future prospects of this domain.
 A detailed assessment of the current market landscape of monkeypox therapeutics / vaccines that are approved / under development, based on several relevant parameters, such as phase of development (approved, clinical and preclinical / discovery), type of product (therapeutic drugs and vaccines), type of molecule (small molecules and biologics), type of dosage form (tablets, capsules, liquids, powders and others), route of administration (oral, intravenous, percutaneous and subcutaneous). In addition, it provides details on monkeypox drug / vaccine developers, along with analyses based on their year of establishment, type of player (Industry and Non-Industry), company size (Small companies: ?50 employees, Mid-sized companies: 51-500 employees and Large companies: >500 employees), geographical location (North America, Europe, Asia Pacific and Rest of the World) and leading players (in terms of number of therapeutics / vaccines in pipeline).
 A detailed assessment of the current market landscape of monkeypox diagnostic kits, based on several relevant parameters, such as type of sample analyzed (lesion swab / rash exudate, serum, blood, respiratory samples, plasma, scab specimen and others), kit components (primer, probe, positive control, negative control, internal control, buffer, enzyme mix, reaction mix, PCR grade water and others), clade of virus detected (monkeypox virus - clade unspecified, West African clade, Congo Basin clade and orthopox virus - including monkeypox), detection method (Polymerase Chain Reaction and others), application area (clinical diagnostics and research), type of kit (DNA detection kit, antibody detection kit, antigen detection kit), quantity of sample required (2-10 µL, 11-50 µL, 51-100 µL and > 100 µL), turnaround time (5-30 minutes, 31-60 minutes, 61-90 minutes and > 90 minutes), limit of detection (100-200 copies/ mL, 201-500 copies/ mL, 501-1,000 copies/ mL and > 1,000 copies/ mL), number of tests per kit (15-50 tests/ kit, 51-150 tests/ kit, 151-500 tests/ kit and > 500 tests/ kit), shelf life (1-9 months, 9-12 months and 12-24 months) and storage temperature (ultra-low storage (-70°C to -40°C), frozen storage (-40°C to 0°C), chilled storage (2°C to 8°C), cool storage (8°C to 15°C), controlled ambient storage (15°C to 25°C) and incubator storage (25°C to 60°C)). In addition, it provides details on monkeypox diagnostic kits developers, along with analyses based on their year of establishment, company size (Small companies: ?50 employees, Mid-sized companies: 51-500 employees, Large Companies: 501 - 1,000 and Very Large companies: >1,000 employees), geographical location (North America, Europe, Asia Pacific and Rest of the World), type of developer (Industry and Non-Industry), and leading players (in terms of number of kits provided).
 A product competitiveness analysis of monkeypox detection kits based on various relevant parameters, namely supplier power (in terms of the experience of the developer) and product competitiveness (in terms of type of clade of virus detected, number of kit component(s), number of sample(s) used, turnaround time, number of tests per kit, storage temperature, kit shelf life, type of detection method, and type of kit).
 Elaborate profiles of prominent players engaged in the development of monkeypox therapeutics / vaccines and diagnostic kits, featuring a brief overview of the company, details on its product portfolio and recent developments with an informed future outlook.
 A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, during the period 2018-2022, covering supply agreements, product development agreements, asset acquisitions, distribution agreements, fill / finish agreements, research and development agreements, and technology integration agreements.
 An in-depth analysis on various grants, received since the year 2003, by players engaged in this field based on year of award, support period, amount awarded, funding institute, type of grant application, activity code, type of study section, purpose of grant, prominent program officers, recipient organizations, popular NIH departments and location of recipient organizations.
 A detailed analysis of more than 200 peer-reviewed, scientific articles related to research on monkeypox therapeutics / vaccines and diagnostic kits, over last five years, based on several relevant parameters, such as year of publication, type of publication, most popular journals, popular keywords, most active publishers, most popular affiliations, and distribution by geography.
 A qualitative analysis of the five competitive forces, including threats for new entrants, bargaining power of drug developers, bargaining power of buyers, threats of substitute products and rivalry among existing competitors under an insightful Porter's Five Forces framework.

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
 Type of Product
 Therapeutics
 Vaccines

 Developer
 Bavarian Nordic
 Emergent BioSolutions
 KM Biologics
 SIGA Technologies

 Type of Kit
 Polymerase Chain Reaction (PCR) Detection Kits
 Antigen Detection Kits
 Antibody Detection Kits

 Type of End User
 Hospitals and Clinics
 Diagnostic Laboratories
 Other End Users

 Key Geographical Regions
 North America (US and Canada)
 Europe (UK, France, Germany, Spain, Italy, Rest of EU)
 Asia-Pacific (Japan and Australia)
 Rest of the World

Key Questions Answered
 What are the factors driving the overall monkeypox market?
 Who are the key players engaged in the development of monkeypox therapeutics / vaccines, and diagnostic kits?
 How many therapeutics and vaccines are approved for the treatment and prevention of monkeypox?
 What is the count of monkeypox diagnostic kits that are currently available in the market?
 What are the partnership and collaboration trends observed in relation to monkeypox therapeutics / vaccines and diagnostic kits?
 Which segment, in terms of type of product, accounts for the largest monkeypox therapeutics / vaccines market share?
 Which type of diagnostic kit accounts for the largest monkeypox market share?

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/monkeypox-tr

You may also be interested in the following titles:
Lab Automation Market

Cannabis Testing Market


About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#monkeypoxtreatmentmarket #monkeypoxtreatmentmarketgrowth #monkeypox #mpox #monkeypoxtreatment

TIL Therapies market, Industry Analysis, and Forecast to 2035

Owing to their tumor-killing capability and therapeutic superiority to conventional therapies, TIL-based therapies are being actively evaluated to treat advance, incurable oncological disorders by various researchers and industry stakeholders

Roots Analysis is pleased to announce the publication of its recent study, titled, “Global TIL-based Therapy Market (2nd Edition), 2023-2035.”

The study features an in-depth analysis of key drivers and trends related to this domain. Amongst other elements, the report includes:
 A detailed assessment of the current market landscape of TIL-based therapies.
 A detailed analysis of completed, ongoing and planned clinical studies related to TIL-based therapies.
 An insightful analysis highlighting the key opinion leaders (KOLs) in this domain featuring an analysis of the various principal investigators of clinical trials related to TIL-based therapies.
 Elaborate profiles of mid- to late-stage clinical products (phase I/II or above).
 An analysis of various type of partnership that have been inked between several stakeholders in the domain of TIL therapies.
 An analysis of the investments that have been made into companies that have proprietary TIL-based products / technologies.
 An in-depth analysis of patents related to TIL-based therapies, filed / granted till 2022.
 A case study on manufacturing cell therapy products, highlighting the key challenges, and a detailed list of contract service providers and in-house manufacturers involved in this space.
 An elaborate discussion on various factors that form the basis for the pricing of cell-based therapies.
 Elaborate profiles of the several leading players in the domain of TCR cell therapies.

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
 Target Indication(s)
 Melanoma
 Head and Neck Carcinoma
 Chronic Lymphocytic Leukemia
 Sarcoma
 Hepatocellular Carcinoma
 Breast Cancer
 Acute Myeloid Leukemia
 Cervical Carcinoma

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Latin America
 Middle East and North Africa
 Rest of the World

The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its financial information (if available), details about TIL-based product(s), such as information on status of development, technology portfolio (if available), recent developments related to TIL-based therapies and manufacturing capabilities of the players.

 Cellectis
 Cellular Biomedicine Group
 Iovance Biotherapeutics
 Lytix Biopharma
 Phio Pharmaceuticals

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/til-therapie


You may also be interested in the following titles:
Lab Automation Market

Cannabis Testing Market



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#tiltherapiesmarketsize #tiltherapiesmarketgrowth #tilimmunotherapies #tilbasedproducts #tilmarket

Medical Device Coatings market Share, Growth Analysis by 2035

The growing demand for complex medical devices has prompted developers to innovate and introduce biocompatible, high-performance medical device coatings that can meet the operational, clinical, and engineering requirements for these devices.

Presently, multiple types of medical device coatings are available in the market to accommodate the multifunctionality of novel medical devices. A detailed medical device coating market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
 Type of Devices Coated
 Class I Medical Devices
 Class II Medical Devices
 Class III Medical Devices
 Type of Coating Material
 Polymer Coatings
 Metal Coatings
 Other Coatings
 Company Size
 Very Small
 Small
 Mid-sized
 Large
 Very Large
 Key Geographical Region
 North America
 Europe
 Asia
 Rest of the World

Key companies covered in the report
 Advanced Coating
 Biocoat
 Evonik
 Formacoat
 Harland Medical Systems
 Para-Coat Technologies
 Specialty Coating Systems
 SurModics
 TUA Systems

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Medical Device Coating Providers: Market Landscape

5. Company Competitiveness Analysis

6. Surface Modification Technologies and Coating Solutions: Market Landscape

7. Product Competitiveness Analysis

8. Medical Device Coating Providers: Company Profiles

9. Partnerships and Collaborations

10. Medical Device Coating Providers: Pestle Analysis

11. Market Forecast

12. Concluding Remarks

13. Executive Insights

14. Appendix 1: Tabulated Data

15. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/medical-devi

You may also be interested in the following titles:
mRNA Synthesis and Manufacturing Services Market

Lab Automation Market



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#medicaldevicecoatingsmarket #medicaldevicecoatingsmarketgrowth #medicaldevicecoatings #antimicrobialcoatingsformedicaldevices #surfacetreatmenttechnologies